
Sign up to save your podcasts
Or


Gene-sequencing biotech Illumina soars on a new partnership with IBM’s Watson. Analyst Simon Erickson shares why he’s bullish on Illumina’s future. Plus, we discuss two increasingly competitive industries: groceries and restaurants.
By The Motley Fool4.7
16041,604 ratings
Gene-sequencing biotech Illumina soars on a new partnership with IBM’s Watson. Analyst Simon Erickson shares why he’s bullish on Illumina’s future. Plus, we discuss two increasingly competitive industries: groceries and restaurants.

3,216 Listeners

1,489 Listeners

807 Listeners

947 Listeners

523 Listeners

1,166 Listeners

2,182 Listeners

825 Listeners

1,421 Listeners

1,037 Listeners

9,718 Listeners

196 Listeners

827 Listeners

87 Listeners

587 Listeners

1,033 Listeners

53 Listeners